Lanthanum composition
The present invention discloses stable, solid oral pharmaceutical composition comprising Lanthanum carbonate having more than 6 molecules of water per molecule of lanthanum carbonate and pharmaceutically acceptable carriers or diluents, wherein said carrier or diluent excludes monosaccharide/s or disaccharide/s, such that the composition has comparable in-vitro dissolution profile similar to that of FOSRENOL®.Also disclosed is a wet granulation process for making the same.
Mylan Laboratories Ltd.
A A A A
A61K A61K A61K A61K
inventional inventional inventional inventional
Subhash Indu Manoj P Subramanian Rajesh S Balakrishnan Gnanadeva Chalapathy Satish Kumar Nagaraj
Gore Bhushan Kumar Iyer Gupta Chinnu Gudipati Jain Amminabavi